ChinaDaily Briefs

Daily Brief China: BYD, Pop Mart International Group L, Sichuan Kelun-Biotech Biopharm, Dickson Concepts Intl, ENN Energy, 52TOYS Development, Bright Smart Securities, Tencent and more

In today’s briefing:

  • Curator’s Cut: Japan Insurers Vs Banks, the State of the Chinese EV Sector and Asian Ports in Focus
  • Quiddity Leaderboard Hang Seng Index Sep25: BeOne, TME, and Pop Mart Among Our Top Picks
  • Sichuan Kelun Biotech (6990 HK): Price Surge & Global Index Inclusion
  • Dickson Concept (113 HK): More Minority Teeth Bared As Another Scheme Fails
  • Merger Arb Mondays (21 Jul) – ENN Energy, HEC Pharma, Shibaura, Abacus Storage, Insignia, Zeekr
  • Pre-IPO 52TOYS Development – The Business Model and the Concerns Behind
  • Bright Smart (1428 HK): Valuation Update
  • ECM Weekly (21 July 2025) – Muyuan, Unisplendour, NTT, Kasumigaseki, Anthem, Leads, SBI, Ascentage


Curator’s Cut: Japan Insurers Vs Banks, the State of the Chinese EV Sector and Asian Ports in Focus

By Pranav Rao

  • Welcome to Curator’s Cut, a fortnightly roundup of standout themes from the 1,000+ insights published in the past two weeks on Smartkarma
  • In this cut, we compare Japanese insurers versus banks, look at the Chinese EV sector and explore how tariff hikes benefit Asian port operators
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next

Quiddity Leaderboard Hang Seng Index Sep25: BeOne, TME, and Pop Mart Among Our Top Picks

By Janaghan Jeyakumar, CFA

  • The Hang Seng Index is the main benchmark index for Hong Kong stocks. It follows a highly-subjective selection process which makes it difficult to predict index changes.
  • In this insight, we take a look at a group of names with reasonably high likelihood of being involved in index changes during the next review in September 2025.
  • The index changes are expected to be confirmed on 22nd August 2025.

Sichuan Kelun Biotech (6990 HK): Price Surge & Global Index Inclusion

By Brian Freitas

  • The recent placement and price surge in Sichuan Kelun-Biotech Biopharm (6990 HK) could result in the stock being added to a global index in August.
  • Sichuan Kelun-Biotech Biopharm has outperformed its peers as the entire industry has been trading well. There is a small increase in short interest in the stock.
  • Positioning has increased steadily over the last month. Momentum in the stock and its peers could lead to further upside before profit taking kicks in.

Dickson Concept (113 HK): More Minority Teeth Bared As Another Scheme Fails

By David Blennerhassett



Pre-IPO 52TOYS Development – The Business Model and the Concerns Behind

By Xinyao (Criss) Wang

  • For IP toy, the ability to provide a variety of categories is valuable,which means brands have access to diverse/creative designs/production based on IP characteristics, highlighting/interpreting the core of each IP.
  • Driven by top-tier licensed IPs, 52TOYS achieved solid growth, but its revenue scale/profit margin are inferior to peers. Due to intense competition, 52TOYS’s market share may be further squeezed.
  • The post-money valuation after Series C+ Financing is RMB4.27 billion. Based on the analysis, we think valuation of 52TOYS should be lower than Pop Mart (9992 HK), Bloks (325 HK).

Bright Smart (1428 HK): Valuation Update

By Osbert Tang, CFA

  • Bright Smart Securities (1428 HK) rallied by 132% since our last Insight, fueled by the euphoria in the brokerage and securities sector on the HK government’s stablecoin initiative.
  • At HK$16.44, it is at 100% PER premium to the sector average, ex-Guotai Junan International (1788 HK). The risk-reward payoff now looks less attractive.
  • It also implies net profit to grow by 150% by FY31F and priced at 18x PER. This appears stretched in the near term, though long-term prospects stay decent. 

ECM Weekly (21 July 2025) – Muyuan, Unisplendour, NTT, Kasumigaseki, Anthem, Leads, SBI, Ascentage

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, filings and listings have cooled off going into the general summer lull.
  • On the placements front, State Bank Of India (SBIN IN) pulled the trigger on its long touted QIP.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars